News
Wall Street's smartest money has quietly amassed over $150 million in bullish positions, with Goldman Sachs eliminating all ...
Markets around the world, including the US and China, all took a big drop during the uncertainty surrounding President ...
Good relative valuations and an encouraging price action led me to view healthcare positively while keeping in mind the ...
The mood is better than the numbers suggest. The doom-loop panic of March and April is behind us, even though the XBI has ...
Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall ...
Top Create Biotech has filed for an initial public offering. The biotechnology company said Wednesday that it intends to list shares under the ticker symbol TCBG on the Nasdaq Capital Market. Top ...
According to Benzinga Pro, Krystal Biotech's peer group average for short interest as a percentage of float is 13.11%, which ...
1d
Zacks Investment Research on MSNCan RXRX's AI-Based Approach Revolutionize the Drug Discovery Process?Recursion Pharmaceuticals RXRX is redefining the traditional model of drug discovery by harnessing the power of artificial intelligence (AI) through its proprietary RecursionOS platform, developed in ...
Complete Zhengye Biotechnology Holding Ltd. stock information by Barron's. View real-time ZYBT stock price and news, along with industry-best analysis.
Real-time index price for S&P 500 Consumer Discretionary [Sector] (SRCD), along with buy or sell indicators, analysis, charts ...
AbbVie had a rough Thursday, with its stock tumbling throughout the session and closing near the day’s lowest point. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results